Latest market price
15.93
-0.92-5.46%
AKTSQT15Aktis Oncology, Inc.·NASDAQ
15.93-5.46%

Latest SEC Filings

Form category
DescriptionFilingDocument
Sep 24, 20264Statement of changes in beneficial ownership
Aug 13, 202610-QQuarterly report
Aug 13, 20268-KCurrent report
Jul 21, 20264Statement of changes in beneficial ownership
Jul 20, 2026144Notice of proposed sale of restricted securities
Jul 20, 20264Statement of changes in beneficial ownership
Jul 17, 2026144Notice of proposed sale of restricted securities
Jul 10, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jul 08, 2026144Notice of proposed sale of restricted securities
Jul 08, 2026144Notice of proposed sale of restricted securities
May 14, 2026SC 13GBeneficial ownership statement (passive)
May 11, 202610-QQuarterly report
May 11, 20268-KCurrent report
Apr 16, 20263Initial statement of beneficial ownership
Apr 16, 20268-KCurrent report
Apr 16, 20264Statement of changes in beneficial ownership
Mar 30, 20268-KCurrent report
Mar 30, 202610-KAnnual report
Jan 20, 2026SC 13DBeneficial ownership statement (active)
Jan 20, 2026SC 13DBeneficial ownership statement (active)
Jan 15, 2026SC 13DBeneficial ownership statement (active)
Jan 15, 20263Initial statement of beneficial ownership
Jan 14, 20264Statement of changes in beneficial ownership
Jan 14, 20264Statement of changes in beneficial ownership